FLFlávia Leite-Lima

Flávia Leite-Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flávia Leite-Lima has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Wagner Henriques de Castro

    Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil

    5 shared publications
  • Ricardo Santiago Gomez

    Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    4 shared publications
  • Felipe Eduardo Baires Campos

    Department of Oral and & Maxillofacial Surgery, Clinical Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    2 shared publications
  • Felipe Paiva Fonseca

    Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    2 shared publications
  • Luiz Felipe Cardoso Lehman

    Department of Dental Surgery, Newton Paiva University Center, Belo Horizonte, Brazil

    2 shared publications
  • Marina Gonçalves Diniz

    Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    2 shared publications

Latest Publications

  • Open Access

    Malignant Transformed and Non-Transformed Oral Leukoplakias Are Metabolically Different

    by Roberta Rayra Martins-Chaves, Victor Coutinho Bastos, Jéssica Gardone Vitório, Filipe Fideles Duarte-Andrade, Thaís dos Santos Fontes Pereira, Flávia Leite-Lima, Thaís Ellen Chaves Gomes, Yuri Abner Rocha Lebron, Victor Rezende Moreira, Monique Sedlmaier França, et al.

    Understanding the early molecular events driving oral carcinogenesis is vital for diagnosing oral squamous cell carcinoma (OSCC) promptly. While metabolic differences between oral leukoplakia (OLK), OSCC, and healthy oral mucosa have been reported, the metabolic changes distinguishing malignant transformed OLKs (MT-OLK) from non-transformed OLKs (NT-OLK) remain unexplored. Here, we examine the metabolomic profiles of 5 cases of MT-OLK and 15 of NT-OLK to identify key predictive molecules using untargeted high-performance liquid chromatography-mass spectrometry. The potentially discriminant compounds were highlighted through a robust statistical analysis workflow, and the dysregulated metabolic pathways were illustrated by enrichment analysis. Seventeen molecular features, primarily lipids—including phospholipids, oxidised lipids, cholesteryl esters, and fatty acids—were identified as discriminants between MT-OLK and NT-OLK across statistical and bioinformatic approaches. Pathway enrichment analysis revealed alterations in lipid metabolism, particularly fatty acid synthesis and degradation, steroid hormone biosynthesis, and glycerophospholipid metabolism. Predictive models showed high accuracy (AUC = 0.88) in distinguishing the two groups. This study suggests that metabolomics has the potential to differentiate between MT-OLK and NT-OLK by identifying candidate biomarkers that may contribute to the understanding of malignant transformation. Validation in larger cohorts is warranted to translate these findings into clinical practice.


  • Surgical management of conventional ameloblastoma: a retrospective cohort study over the past 21 years

    by Flávia Leite-Lima, Roberta Rayra Martins-Chaves, Wagner Henriques de Castro, Ricardo Santiago Gomez

    Conventional ameloblastoma presents infiltrative behavior and its treatment ranges from enucleation combined with adjuvant therapies to marginal/segmental resection. The purpose of this study is to present a cohort of twenty-four patients with ameloblastoma treated in the same institution after marginal/segmental resection for the past 21 years. All cases had diagnosis confirmation by incisional biopsy. Patients with an unconfirmed diagnosis and missing follow-up information were excluded. Data were categorized into clinicopathological, surgical and recurrence aspects. Thirteen patients were females (54%). The mean age was 40.2 years. Mandible was the most affected site (91%). The mean length of the lesions was 4.10 cm (± 2.06) and the multilocular aspect was predominant (83%). Root resorption (37.5%), tooth displacement (45.8%) and cortical perforation (45.8%) were noticed. Histologically, most of the cases were follicular (n = 19,79%). Microscopic analysis showed positive margins in four cases. Patients were treated by marginal (n = 19) and segmental (n = 5) resections. Recurrence occurred in two cases (8.33%). Both primary and recurrent ameloblastomas were treated through marginal resections and no recurrence was observed during the past 9 and 5 years after the last intervention, respectively. The overall mean follow-up was 79.25 months and patients are still monitored over these years. Marginal/segmental resection of conventional ameloblastoma is associated with a low recurrence rate.


  • MULTICYSTIC AMELOBLASTOMA: A CASE REPORT WITH A 14-YEAR FOLLOW-UP

    by Flávia Leite-Lima, Felipe Eduardo Baires Campos, Luiz Felipe Cardoso Lehman, Ricardo Santiago Gomez, Wagner Henriques de Castro

  • A conservative approach for unicystic ameloblastoma: Retrospective clinic‐pathologic analysis of 12 cases

    by Flávia Leite‐Lima, Roberta Rayra Martins‐Chaves, Felipe Paiva Fonseca, Peter A. Brennan, Wagner Henriques de Castro, Ricardo Santiago Gomez

    Background: Unicystic ameloblastoma is an encapsulated odontogenic neoplasm with a single cyst cavity. The conservative or aggressive surgical approaches used to treat the tumor directly affect recurrence rates. However, there is a lack of a standard protocol that can guide its management.Study Design: We retrospectively reviewed the clinicopathological findings and therapeutical procedures of 12 unicystic ameloblastoma cases treated by the same surgeon during the past 20 years.Methods: All cases of unicystic ameloblastoma diagnosed by biopsy and treated by the same surgeon between 2002 and 2022 were reviewed. Eligibility criteria were patients with completely filled‐out charts containing the follow‐up period and confirmation of the diagnoses based on the microscopic findings of the whole excised specimens. Data collected were categorized into clinical, radiographic, histological, surgical, and recurrence aspects.Results: There was a female predilection (2:1), and ages ranged between 18 and 61 years (mean: 27.25, ±12.45). Almost all (92%) affected the posterior mandible. Radiographically, the mean length of the lesions was 46.14 mm ± 14.28 mm which 92% were unilocular and 8.3% multilocular. Root resorption (n = 7, 58%), tooth displacement (n = 9, 75%), and cortical perforation (n = 5, 42%) were also observed. The mural histological subtype corresponded to 9 (75%) of the cases. The same conservative protocol was performed in all cases. The follow‐up period ranged between 12 and 240 months (~62 ± 65) and recurrence occurred in only one patient (8%).Conclusion: Our findings suggest a conservative approach should be the first option for unicystic ameloblastoma treatment, even for those with mural proliferation.


  • Unveiling metabolic changes in marsupialized odontogenic keratocyst: A pilot study

    by Flávia Leite‐Lima, Victor Coutinho Bastos, Jéssica Gardone Vitório, Filipe Fideles Duarte‐Andrade, Thaís dos Santos Fontes Pereira, Roberta Rayra Martins‐Chaves, Aline Fernanda Cruz, Júlio César Tanos de Lacerda, Yuri Abner Rocha Lebron, Victor Rezende Moreira, et al.

    Objective: We aimed to assess which metabolic pathways would be implicated in the phenotypic changes of the epithelial lining of odontogenic keratocyst after marsupialization, comparing pre‐ and post‐marsupialized lesions with adjacent oral mucosa.Materials and Methods: Eighteen formalin‐fixed and paraffin‐embedded tissues from six subjects were divided into three paired groups: odontogenic keratocyst pre‐ (n = 6) and post‐marsupialization (n = 6), and adjacent oral mucosa (n = 6). The metabolic pathways found in these groups were obtained by high‐performance liquid chromatography‐mass spectrometry‐based untargeted metabolomics performed.Results: Through putative metabolite annotation followed by pathway enrichment and predictive analysis with automated algorithms (Mummichog and Gene Set Enrichment Analysis), we found differences in many cellular processes that may be involved in inflammation, oxidative stress response, keratinocyte‐basal membrane attachment, differentiation, and proliferation functions, all relevant to odontogenic keratocyst pathobiology and the phenotype acquired after marsupialization.Conclusion: Our study was able to identify several metabolic pathways potentially involved in the metaplastic changes induced by marsupialization of odontogenic keratocysts. An improved comprehension of this process could pave the way for the development of targeted therapies.


  • A nodule in the temporomandibular joint area

    by Flávia Leite-Lima, Felipe Paiva Fonseca, Ricardo Santiago Gomez, Luiz Felipe Cardoso Lehman, Wagner Henriques de Castro, Felipe Eduardo Baires Campos

  • Surgical management x recurrence of Odontogenic myxoma: Literature review and case reports

    by Flávia Leite-Lima, Joanna Farias da Cunha, Luiz Felipe Cardoso Lehman, Felipe Eduardo Baires Campos, Wagner Henriques de Castro